Neutralization of vascular endothelial growth factor antiangiogenic isoforms or administration of proangiogenic isoforms stimulates vascular development in the rat testis

被引:18
|
作者
Baltes-Breitwisch, Michelle M. [1 ]
Artac, Robin A. [1 ]
Bott, Rebecca C. [1 ]
McFee, Renee M. [1 ]
Kerl, Jill G. [1 ]
Clopton, Debra T. [1 ]
Cupp, Andrea S. [1 ]
机构
[1] Univ Nebraska, Dept Anim Sci, Lincoln, NE 68583 USA
关键词
CORD FORMATION; CELL-DIFFERENTIATION; MAMMALIAN GONAD; TESTICULAR-DIFFERENTIATION; TRANSGENIC MICE; SPLICE VARIANT; XY GONAD; IN-VIVO; EXPRESSION; MIGRATION;
D O I
10.1530/REP-09-0456
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vascular endothelial growth factor A (VEGFA) plays a role in both angiogenesis and seminiferous cord formation, and alternative splicing of the Vegfa gene produces both proangiogenic isoforms and antiangiogenic isoforms (B-isoforms). The objectives of this study were to evaluate the expression of pro- and antiangiogenic isoforms during testis development and to determine the role of VEGFA isoforms in testis morphogenesis. Quantitative RT-PCR determined that Vegfa_165b mRNA was most abundant between embryonic days 13.5 and 16 (E13.5 and 16; P < 0.05). Compared with ovarian mRNA levels, Vegfa_120 was more abundant at E13-14 (P < 0.05), Vegfa_164 was less abundant at E13 (P < 0.05), and Vegfa_165b tended to be less abundant at E13 (P < 0.09) in testes. Immunohistochemical staining localized antiangiogenic isoforms to subsets of germ cells at E14-16, and western blot analysis revealed similar protein levels for VEGFA_165B, VEGFA_189B, and VEGFA_206B at this time point. Treatment of E13 organ culture testes with VEGFA_120, VEGFA_164, and an antibody to antiangiogenic isoforms (anti-VEGFAxxxB) resulted in less organized and defined seminiferous cords compared with paired controls. In addition, 50 ng/ml VEGFA_120 and VEGFA_164 treatments increased vascular density in cultured testes by 60 and 48% respectively, and treatment with VEGFAxxxB antibody increased vascular density by 76% in testes (0.5 ng/ml) and 81% in ovaries (5 ng/ml) compared with controls (P < 0.05). In conclusion, both pro- and antiangiogenic VEGFA isoforms are involved in the development of vasculature and seminiferous cords in rat testes, and differential expression of these isoforms may be important for normal gonadal development. Reproduction (2010) 140 319-329
引用
收藏
页码:319 / 329
页数:11
相关论文
共 50 条
  • [41] LOCALIZATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) ISOFORMS IN A TRANSFECTED CELL-LINE
    PARK, JE
    KELLER, GA
    FERRARA, N
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 : A333 - A333
  • [42] Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature
    Grunstein, J
    Masbad, JJ
    Hickey, R
    Giordano, F
    Johnson, RS
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (19) : 7282 - 7291
  • [43] Relative expression of vascular endothelial growth factor isoforms in squamous cell carcinoma of the head and neck
    Wilkie, Mark D.
    Emmett, Maxine S.
    Santosh, Shilpa
    Lightbody, Kathryn A.
    Lane, Steven
    Goodyear, Paul W.
    Sheard, Jon D.
    Boyd, Mark T.
    Pritchard-Jones, Rowan O.
    Jones, Terence M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (05): : 775 - 781
  • [44] New vascular endothelial growth factor isoforms promise to increase myocardial perfusion without stealing
    Mangialardi, Giuseppe
    Madeddu, Paolo
    HEART, 2016, 102 (21) : 1697 - 1698
  • [45] Dermal papilla cells express four isoforms of vascular endothelial growth factor mRNA.
    Sim, WY
    Baik, SH
    Park, IK
    Kim, NI
    Haw, CR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 535 - 535
  • [46] Vascular endothelial growth factor (VEGF) Isoforms in autosomal dominant polycystic kidney disease (ADPKD).
    Tao, YX
    Jun, K
    Schrier, RW
    Edelstein, CL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 582A - 582A
  • [47] Differential expression of human vascular endothelial growth factor isoforms and new approaches for therapeutic angiogenesis
    Skryabin, K.G.
    Mattskeplishvili, S.T.
    Kamardinov, D.Kh.
    Prasolov, V.S.
    El'darov, M.A.
    Kirpichnikov, M.P.
    Bokeriya, L.A.
    Petrov, R.V.
    Zinov'eva, M.V.
    Ivanov, D.S.
    Buziashvili, Yu.I.
    Doklady Akademii Nauk, 2004, 397 (06) : 838 - 841
  • [48] Characterization of novel VEGF (vascular endothelial growth factor)-C splicing isoforms from mouse
    Wang, Zhen-Guo
    Puri, Tipu S.
    Quigg, Richard J.
    BIOCHEMICAL JOURNAL, 2010, 428 : 347 - 354
  • [49] Pulmonary expression of vascular endothelial growth factor and myosin isoforms in rats with congenital diaphragmatic hernia
    Okazaki, T
    Sharma, HS
    Aikawa, M
    Yamataka, A
    Nagai, R
    Miyano, T
    Tibboel, D
    JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (03) : 391 - 394
  • [50] Aflibercept - Antiangiogenic agent vascular endothelial growth factor inhibitor
    Sorbera, L. A.
    DRUGS OF THE FUTURE, 2007, 32 (02) : 109 - 117